NCT07293754 2026-02-17
RaPTR-101
Repertoire Immune Medicines
Phase 1/2 Recruiting
Clinical Trials
9 trialsNCT07326488 2026-01-08
A Study of MHB009C in Patients With Advanced Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Not yet recruiting
NCT07126665 2025-11-18
A Study of MHB088C Combined With MHB039A in Patients With Advanced Malignant Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT07192107 2025-09-25
A Study of MHB042C in Patients With Advanced Solid Tumors
Minghui Pharmaceutical (Hangzhou) Ltd
Phase 1/2 Recruiting
NCT07077252 2025-07-22
Phase I/II Study of SCTB39G in Advanced Solid Tumours
Sinocelltech Ltd.
Phase 1/2 Not yet recruiting
NCT07050641 2025-07-04
Phase I/II Study of SCTB39-1 in Advanced Solid Tumours
Sinocelltech Ltd.
Phase 1/2 Recruiting
NCT04165590 2024-02-20
Plasmodium Immunotherapy for Advanced Malignant Solid Tumors
CAS Lamvac Biotech Co., Ltd.
Phase 1/2 Recruiting
NCT05396339 2023-07-19
A Clinical Trial to Evaluate the Effect of IAE0972 in Patients With Advanced Malignant Solid Tumors.
SUNHO（China）BioPharmaceutical CO., Ltd.
Phase 1/2 Unknown
NCT03171220 2017-06-06
NRT-01
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1/2 Unknown